Elephas Biosciences partners with Invitrocue to promote elive platform in Singapore and Malaysia

Lupin spins out two oncology programmes to Kaveri Therapeutics

Fuse Oncology launches new prescribing and treatment-intent solution FuseRx

Tempus agrees to acquire Personalis in USD1.5bn precision oncology deal

Evaxion to present three-year cancer vaccine data at ESMO Congress 2026

Ananda Pharma doses first patient in MRX1 clinical trial of patients with chemotherapy induced peripheral neuropathy

Raidium introduces AI-powered oncology imaging workflow for US cancer centres

Galmed announces breakthrough development of SCD1 inhibitor Aramchol for cardiac fibrosis

Intensity Therapeutics restarts breast cancer Phase 2 clinical trial

Merck reports positive Phase 3 results for KEYTRUDA in advanced endometrial cancer

Kelun-Biotech's Phase III study of sac-TMT in combination with pembrolizumab meets primary endpoint

AstraZeneca signs global licence deal with Dizal for lung cancer drug Zegfrovy

Summit Therapeutics sells Phase III antibiotic asset ridinilazole to Biossil

European Commission approves Erbitux combination for first-line BRAF V600E-mutant mCRC

Newbury Pharmaceuticals receives Swedish approval for generic tofacitinib